-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HSJYY3QcAueNuDaYICx6PTJU4XrshVUWzLgrwZqOLV2IgaL0/Qbb9f0zIg3pH9NF CeoDnm+BqVIZ2Jh9fb2UZQ== 0001181152-10-000002.txt : 20100521 0001181152-10-000002.hdr.sgml : 20100521 20100521125803 ACCESSION NUMBER: 0001181152-10-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100520 FILED AS OF DATE: 20100521 DATE AS OF CHANGE: 20100521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONDURANT STUART CENTRAL INDEX KEY: 0001181152 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 10850310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-05-20 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001181152 BONDURANT STUART 205 UNIVERSITY DRIVE CHAPEL HILL NC 27514 1 0 0 0 Common Stock 17844 D Stock Options (to buy) 25.38 2010-05-20 4 A 0 10140 0 A 2010-05-20 2020-05-20 Common Stock 10140 10140 D Stock Options (to buy) 19.86 2009-05-20 2019-05-20 Common Stock 13577 13577 D Stock Options (to buy) 42.77 2008-05-21 2018-05-20 Common Stock 6265 6265 D Stock Options (to buy) 33.82 2007-05-16 2017-05-16 Common Stock 6126 6126 D Stock Options (to buy) 35.38 2006-05-17 2016-05-16 Common Stock 3973 3973 D Stock Options (to buy) 23.79 2005-05-18 2015-05-17 Common Stock 5458 5458 D Lisa C. Noecker attorney-in-fact for Stuart Bondurant 2010-05-21 -----END PRIVACY-ENHANCED MESSAGE-----